Utility of CA 15-3 and CEA in monitoring breast cancer patients with bone metastases: Special emphasis on ''spiking'' phenomena


Yasasever V., DINCER M., CAMLICA H., KARALOGLU D., DALAY N.

CLINICAL BIOCHEMISTRY, vol.30, no.1, pp.53-56, 1997 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 30 Issue: 1
  • Publication Date: 1997
  • Doi Number: 10.1016/s0009-9120(96)00133-6
  • Journal Name: CLINICAL BIOCHEMISTRY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.53-56
  • Istanbul University Affiliated: Yes

Abstract

Objectives: CA 15-3 and CEA are considered useful tumor markers in monitoring breast cancer patients. This study was undertaken to specifically evaluate the transient elevations in these markers that are observed during systemic treatment for metastatic disease. This phenomenon has been termed ''spiking.''